Ifergan I - Search Results

1

Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche.

Plebanek MP, Angeloni NL, Vinokour E, Li J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J, Miller SD, Ifergan I, Lee Y, Osman I, Thaxton CS, Volpert OV. Plebanek MP, et al. Among authors: ifergan i. Nat Commun. 2017 Nov 6;8(1):1319. doi: 10.1038/s41467-017-01433-3. Nat Commun. 2017. PMID: 29105655 Free PMC article.

2

Potential for Targeting Myeloid Cells in Controlling CNS Inflammation.

Ifergan I, Miller SD. Ifergan I, et al. Front Immunol. 2020 Oct 6;11:571897. doi: 10.3389/fimmu.2020.571897. eCollection 2020. Front Immunol. 2020. PMID: 33123148 Free PMC article. Review.

3

Experimental Autoimmune Encephalomyelitis in Mice.

Terry RL, Ifergan I, Miller SD. Terry RL, et al. Among authors: ifergan i. Methods Mol Biol. 2016;1304:145-60. doi: 10.1007/7651_2014_88. Methods Mol Biol. 2016. PMID: 25005074 Free PMC article.

4

Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.

Ifergan I, Chen S, Zhang B, Miller SD. Ifergan I, et al. J Immunol. 2016 Feb 15;196(4):1455-1459. doi: 10.4049/jimmunol.1501965. Epub 2016 Jan 18. J Immunol. 2016. PMID: 26783338 Free PMC article.

5

Intravenous immune-modifying nanoparticles as a therapy for spinal cord injury in mice.

Jeong SJ, Cooper JG, Ifergan I, McGuire TL, Xu D, Hunter Z, Sharma S, McCarthy D, Miller SD, Kessler JA. Jeong SJ, et al. Among authors: ifergan i. Neurobiol Dis. 2017 Dec;108:73-82. doi: 10.1016/j.nbd.2017.08.006. Epub 2017 Aug 18. Neurobiol Dis. 2017. PMID: 28823935 Free PMC article.

6

Methodology for in vitro Assessment of Human T Cell Activation and Blockade.

Podojil JR, Ifergan I, Chiang MY, Meeks JJ, Miller SD. Podojil JR, et al. Among authors: ifergan i. Bio Protoc. 2020 Jun 5;10(11):e3644. doi: 10.21769/BioProtoc.3644. eCollection 2020 Jun 5. Bio Protoc. 2020. PMID: 33659314 Free PMC article.

7

Herpesvirus Entry Mediator Binding Partners Mediate Immunopathogenesis of Ocular Herpes Simplex Virus 1 Infection.

Park SJ, Riccio RE, Kopp SJ, Ifergan I, Miller SD, Longnecker R. Park SJ, et al. Among authors: ifergan i. mBio. 2020 May 12;11(3):e00790-20. doi: 10.1128/mBio.00790-20. mBio. 2020. PMID: 32398314 Free PMC article.

8

PLG nanoparticles target fibroblasts and MARCO+ monocytes to reverse multiorgan fibrosis.

Xu D, Bhattacharyya S, Wang W, Ifergan I, Wong MAC, Procissi D, Yeldandi A, Bale S, Marangoni RG, Horbinski C, Miller SD, Varga J. Xu D, et al. Among authors: ifergan i. JCI Insight. 2022 Mar 8;7(5):e151037. doi: 10.1172/jci.insight.151037. JCI Insight. 2022. PMID: 35104243 Free PMC article.

9

Biodegradable nanoparticles induce cGAS/STING-dependent reprogramming of myeloid cells to promote tumor immunotherapy.

Podojil JR, Cogswell AC, Chiang MY, Eaton V, Ifergan I, Neef T, Xu D, Meghani KA, Yu Y, Orbach SM, Murthy T, Boyne MT, Elhofy A, Shea LD, Meeks JJ, Miller SD. Podojil JR, et al. Among authors: ifergan i. Front Immunol. 2022 Aug 18;13:887649. doi: 10.3389/fimmu.2022.887649. eCollection 2022. Front Immunol. 2022. PMID: 36059473 Free PMC article.

10

Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.

Edwards RG, Kopp SJ, Ifergan I, Shui JW, Kronenberg M, Miller SD, Longnecker R. Edwards RG, et al. Among authors: ifergan i. Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):282-291. doi: 10.1167/iovs.16-20668. Invest Ophthalmol Vis Sci. 2017. PMID: 28114589 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page